Overview
Siddhartha Sivaramakrishnan focuses his practice on the representation of investment bank underwriters, issuers and vendors in a wide range of US and international equity and debt capital markets transactions. These include numerous primary and secondary offerings under Rule 144A and Regulation S, US private placements and SEC-registered offerings. Siddhartha also advises on M&A and structured financings, offerings of equity-linked instruments and investment grade, high yield and sovereign debt offerings. Siddhartha’s practice focuses on the Asia Pacific and EMEA markets.
Siddhartha counsels on financial institution regulatory and compliance matters, including cross border licensing and reporting requirements; senior managers’ responsibilities and conduct; insider dealing and market abuse; and the impact of US and European regulatory change on financial market participants.
Results
- Advised Kotak, Citi, Nomura and Haitong on the US$ 872 million IPO on the Bombay Stock Exchange and Rule 144A/Regulation S global offering of Gland Pharma, a leading generic injectables manufacturer majority owned by global pharmaceutical major Shanghai Fosun Pharma*
- Advised Credit Suisse, Bank of America and UBS as joint sponsors on the US$ 1.31 billion SEC registered global offering and secondary listing on the Hong Kong Stock Exchange of New Oriental Education and Technology, China’s largest private educational service provider*
- Advised State Grid Corporation China, the world’s largest utility corporation, on its US$7.7 billion and US$10 billion MTN programmes and drawdowns of US$5 billion and US$2.1 billion, respectively*
- Advised Carlyle as selling shareholder on the US$1.4 billion IPO and Rule 144A/Regulation S global offering of SBI Cards, India’s second largest credit card issuer*
- Advised Wijaya Karya, an Indonesian engineering and construction major, on its IDR 5,400 billion (US$400 million) global offering of rupiah denominated, dollar settled komodo bonds, the largest such issuance as of its date. BNP, HSBC, Mandiri and MUFG were the initial purchasers*
- Advised ReNew Power, India’s largest renewable energy company, on its proposed IPO on the Bombay Stock Exchange and Rule 144A/Regulation S global offering*
- Advised Citi, Deutsche Bank and UBS as international selling agents on the US$276 million IPO on the Indonesia Stock Exchange and Rule 144A/ Regulation S global offering by Cikarang Listrindo, an independent power producer*
- Advised Khazanah, the Malaysian sovereign wealth fund, on its US$500 million Regulation S offering of exchangeable bonds. CIMB, Credit Suisse and J.P. Morgan were the joint lead managers*
- Advised Maybank Kim Eng, UOB and DBS on the US securities law aspects of the SG$297 million IPO on the Singapore Stock Exchange and Regulation S international offering of Aztech Global, a technology hardware manufacturer*
- Advised Hibiscus Petroleum, a Malaysian oil and gas E&P company, on the US securities law aspects of its proposed US$490 million issuance of convertible preference shares to fund certain acquisitions*
- Advised a global investment fund on market manipulation regulations in various Asian and European jurisdictions*
- Advised an EMEA investment fund on its continuous reporting obligations in certain Asian jurisdictions*
- Advised an EMEA investment bank on US broker-dealer chaperoning arrangements*
- Advised a global investment bank on its establishment of an onshore securities platform in an emerging Asian market*
*Matter handled prior to joining McDermott
Recognitions
- Chambers Global, Capital Markets: International, Singapore, 2022
- Chambers Asia Pacific, Capital Markets: International, Singapore, 2022
- Legal 500, Capital Markets: Equity And Debt: Foreign Firms, 2021
- IFLR 1000, Capital Markets Debt & Equity, 2021
Credentials
Education
Yale University
University of Oxford
Admissions
England & Wales
New York
